KELLEY BELTRAN: Open Payments
NPI 1063949600 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,458 in 145 payments from 24 companies in 2025. Trend: 2023 $1,347 · 2024 $1,987 · 2025 $2,458
Food & beverage: $2,458
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 45 | $372 |
| ABBVIE INC. | 16 | $332 |
| AstraZeneca Pharmaceuticals LP | 10 | $283 |
| PFIZER INC. | 14 | $266 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $260 |
| Lilly USA, LLC | 9 | $142 |
| Astellas Pharma US Inc | 6 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lundbeck LLC | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $73 |
Products named: VOQUEZNA, AIRSUPRA, Kerendia, NURTEC ODT, Veozah, QULIPTA, MOUNJARO, UBRELVY.
Industry payments across WI — which companies pay providers there.
